Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The interest coverage ratio is -1569.80x as of the fiscal period ended Saturday, June 30, 2018.
Reported quarterly interest coverage; no daily interpolation.
Limited quarterly history available
Interest Coverage needs at least three reported quarters before a meaningful chart is shown.
INTEREST COVERAGE RATIO
-1569.80x
INTEREST COVERAGE RATIO AVG TTM
N/A
INTEREST COVERAGE RATIO AVG 3Y
N/A
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-5.63x
median of 440 covered companies
CURRENT VS SECTOR MEDIAN
-27758.03%
vs the sector median at left
Fulcrum Therapeutics, Inc.
Market Cap
$284.21M
Interest Coverage Ratio
-1569.80x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$280.60M
Interest Coverage Ratio
-25.79x
TTM Avg
0.59x
3Y Avg
0.59x
5Y Avg
0.59x
Market Cap
$285.94M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$278.87M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$289.25M
Interest Coverage Ratio
-23.92x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$276.08M
Interest Coverage Ratio
-120.84x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$290.79M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$290.97M
Interest Coverage Ratio
-3588.65x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$271.27M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Fulcrum Therapeutics, Inc. (FULC) | $284.21M | -1569.80x | N/A | N/A | N/A |
| Aurora Cannabis Inc. (ACB)vs › | $280.60M | -25.79x | 0.59x | 0.59x | 0.59x |
| Indaptus Therapeutics, Inc. (INDP)vs › | $285.94M | N/A | N/A | N/A | N/A |
| Fate Therapeutics, Inc. (FATE)vs › | $278.87M | N/A | N/A | N/A | N/A |
| Abeona Therapeutics Inc. (ABEO)vs › | $289.25M | -23.92x | N/A | N/A | N/A |
| Rocket Pharmaceuticals, Inc. (RCKT)vs › | $276.08M | -120.84x | N/A | N/A | N/A |
| BridgeBio Oncology Therapeutics Inc. (BBOT)vs › | $290.79M | N/A | N/A | N/A | N/A |
| Standard BioTools Inc. (LAB)vs › | $290.97M | -3588.65x | N/A | N/A | N/A |
| EyePoint Pharmaceuticals, Inc. (EYPT)vs › | $271.27M | N/A | N/A | N/A | N/A |
| Larimar Therapeutics, Inc. (LRMR)vs › | $297.62M | N/A | 40.84x | 40.84x | 40.84x |
Interest Coverage
-1569.8x
Debt/Equity
0.02
Current Ratio
31.35
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2018-06-30 | -1569.80x |
